PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹4,842 Cr | ₹4,175 Cr | ₹3,903 Cr | ₹3,854 Cr | ₹3,252 Cr |
What is the latest Total Liabilities ratio of PFIZER ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹4,842 Cr |
| Mar2024 | ₹4,175 Cr |
| Mar2023 | ₹3,903 Cr |
| Mar2022 | ₹3,854 Cr |
| Mar2021 | ₹3,252 Cr |
How is Total Liabilities of PFIZER Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,842 Cr | 15.98 | |
| Mar2024 | ₹4,175 Cr | 6.96 | |
| Mar2023 | ₹3,903 Cr | 1.29 | |
| Mar2022 | ₹3,854 Cr | 18.48 | |
| Mar2021 | ₹3,252 Cr | - | |
Compare Total Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹20,738.9 Cr | 2.7% | -7% | -20.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,785.0 Cr | 0.4% | -4.6% | 6.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,242.0 Cr | 0.7% | -1.1% | 2.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,058.0 Cr | 2.9% | -1.2% | 42.7% | Stock Analytics | |
| CIPLA | ₹111,180.0 Cr | -1.5% | 5.5% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,149.0 Cr | 0.4% | -0.6% | 1.3% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 2.7% |
-7% |
-20.2% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses